Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 01/07/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 409 publications
Developments of MEK inhibitors as future cancer therapies: what have we learned from preclinical and clinical studies?
Journal: Expert opinion on investigational drugs
Published: December 05, 2025
Turning the Tables: How Encorafenib and Binimetinib are Reshaping NSCLC Treatment.
Journal: Cancer investigation
Published: December 04, 2025
Targeting BRAF Class II and III Mutations in NSCLC with the pan-RAF inhibitor Exarafenib Reveals ARAF-KSR1-Mediated Resistance and Rational Combination Strategies.
Journal: Research square
Published: November 24, 2025
Targeting BRAF Class II and III Mutations in NSCLC with the pan-RAF inhibitor Exarafenib Reveals ARAF-KSR1-Mediated Resistance and Rational Combination Strategies.
Journal: Research square
Published: November 24, 2025
Precision medicine in hemato-oncology - treatment of refractory multiple myeloma with massive extramedullary involvement using BRAF/ MEK inhibitors.
Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
Published: October 30, 2025
Antitumor Activity of Metformin in Combination with Binimetinib Against Melanoma Cells.
Journal: International journal of molecular sciences
Published: October 23, 2025
Updated Overall Survival Analysis From the Phase 2 PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 19, 2025
Corrigendum to: A Phase 2 Study of Encorafenib in Combination with Binimetinib in Patients with Metastatic BRAF-Mutated Thyroid Cancer in Japan.
Journal: Thyroid : official journal of the American Thyroid Association
Published: September 30, 2025
Intracranial antitumor efficacy of combination treatment with encorafenib plus binimetinib in BRAF V600E-mutated anaplastic thyroid carcinoma.
Journal: Auris, nasus, larynx
Published: September 19, 2025
Noninvasive Therapeutic Monitoring of Circulating Tumor DNA in BRAF-Mutant Metastatic Colon Cancer Using Droplet Digital PCR, Next-Generation Sequencing, and Fragmentomics.
Journal: Case reports in oncological medicine
Published: August 20, 2025
Last Updated: 01/07/2026